Correlational studies indicate a close association between caspase-9 expression and disease severity, however further interventional studies in animal models of DCM would be helpful to establish whether inhibiting caspase-9 may provide therapeutic benefit in these disorders. This evidence concerns the gene CASP9 and familial dilated cardiomyopathy.